KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Cardlytics (CDLX) FCF Margin (2017 - 2025)

Cardlytics (CDLX) has disclosed FCF Margin for 9 consecutive years, with 22.59% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, FCF Margin rose 253.0% year-over-year to 22.59%, compared with a TTM value of 3.78% through Dec 2025, up 751.0%, and an annual FY2025 reading of 3.78%, up 751.0% over the prior year.
  • FCF Margin was 22.59% for Q4 2025 at Cardlytics, up from 3.37% in the prior quarter.
  • Across five years, FCF Margin topped out at 22.59% in Q4 2025 and bottomed at 31.24% in Q3 2022.
  • Average FCF Margin over 5 years is 8.22%, with a median of 9.68% recorded in 2022.
  • The sharpest move saw FCF Margin soared 3275bps in 2023, then tumbled -1807bps in 2024.
  • Year by year, FCF Margin stood at 1.69% in 2021, then plummeted by -267bps to 6.18% in 2022, then crashed by -59bps to 9.86% in 2023, then skyrocketed by 303bps to 20.05% in 2024, then increased by 13bps to 22.59% in 2025.
  • Business Quant data shows FCF Margin for CDLX at 22.59% in Q4 2025, 3.37% in Q3 2025, and 1.91% in Q2 2025.